Skip to content

Analyzing ultrasound features by radiomics to define the junction zone of adenomyosis

Analyzing ultrasound features by radiomics to define the junction zone of adenomyosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090055
Enrollment
Unknown
Registered
2024-09-23
Start date
2024-07-08
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

Trial group (Adenomyosis group):None
Control group (Uterine Fibroids group):None

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 18 years old or over; 2. Patients with adenomyopathy or uterine myoma who plan to undergo uterine ablation due to symptoms (menstrual pain, menorrhagia, dysmenorrhea, chronic pelvic pain, etc.); 3. All patients were confirmed to have adenomyosis or uterine myoma by MRI examination before surgery (which is a necessary procedure before ablation); 4. No other malignant gynecological diseases, as well as serious heart and lung diseases; 5. Voluntarily sign an informed consent form and follow the requirements of the plan.

Exclusion criteria

Exclusion criteria: 1. Menopausal women; 2. Pregnant women; 3. Using of intrauterine devices or hormones for contraception; 4. Previously received surgery for adenomyosis or fibroids, or minimally invasive treatment for excessive menstruation; 5. No complete ultrasound or MRI examination data available.

Design outcomes

Primary

MeasureTime frame
Young's modulus;Thickness of junction zone;

Countries

China

Contacts

Public ContactHuang Ying

Shengjing Hospital of China Medical University

huangying712@163.com+86 24 96615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026